Erythropoietin – An Outstanding Success for Genetic Modification

Abstract

Get full access to this article

View all access options for this article.

References

Viault

. Sur l'augmenetation considerable du nombres des globules rouge dans le sang chez les habitant des haut plateaux de l'Amerique du Sud. C R Acad Sci (Paris) 1890; 111:917–8.

Carnot

Delandre

. Sur l'activite hemopoietique des differents organes au cours de la regeneration du sang. C R Acad Sci (Paris) 1906; 143:432–5.

Reissman

. Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood 1950; 5:372–80.

Jacobson

Goldwasser

Fried

Plzak

. Role of the kidney in erythropoiesis. Nature 1957; 179:633–4.

Van Stone

Max

. Effect of erythropoietin on the anaemia of peritoneally dialysed anephric rats. Kidney Int 1979; 15:370–5.

Miyake

Kung

CK-H

Goldwasser

. Purification of human erythropoietin. J Biol Chem 1997; 252:5558–64.

Lin

F-K

Suggs

Lin

C-K

. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci 1985; 82:7580–4.

Jacobs

Shoemaker

Rudersdorf

. Isolation and characterisation of genomic and cDNA clones of human erythropoietin. Nature 1995; 313:806–10.

Fried

. The liver as a source of extrarenal erythropoietin production. Blood 1972; 40:671–7.

10.

Eschbach

Adamson

Cook

. Disorders of red cell production in uraemia. Arch Int Med 1970; 126:812–5.

11.

Cattron

Fenton

SSA

Wilson

. A controlled trial of nandrolene decanoate in the treatment of uraemic anaemia. Kidney Int 1977; 12:430–7.

12.

Eschbach

Egrie

Downing

. Correction of the anaemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316:73–8.

13.

Winearls

Oliver

Pippard

. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986; 2:1175–8.

14.

Winearls

. Erythropoietin. Nephrol Dial Transplant 1989; 4:323–6.

15.

Winearls

. Recombinant human erythropoietin: 10 years of clinical experience. Nephrol Dial Transplant 1998; 13 (Suppl 2):3–8.

16.

Ad Hoc Committee for the National Kidney Foundation. Statement on the clinical use of recombinant erythropoietin in anaemia of end-stage renal disease. Am J Kidney Dis 1989; 14:163–9.

17.

Cook

Skikne

Lynch

Reusser

. Estimates of iron sufficiency in the US population. Blood 1986; 68:726–31.

18.

Sundal

Kaesar

. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European Multicentre Study of 150 haemodialysis-dependent patients. Nephrol Dial Transplant 1989; 4:979–87.

19.

Erslev

. The therapeutic role of recombinant erythropoietin in anaemic patients with intact endogenous production of erythropoietin. Sem Oncology 1992; 19:3(Suppl 8):14–8.

20.

Miller

Jones

Piantadosi

. Decreased erythropoietin response in patients with the anaemia of cancer. N Engl J Med 1990; 322:1689–92.

21.

Fischl

Galpin

Levine

. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322:1488–93.

22.

Horina

Petritsch

Schmid

. Treatment of anaemia in inflammatory bowel disease with recombinant human erythropoietin: results in three patients. Gastroent 1993; 104:1828–31.

23.

Means

Olsen

Krantz

. Treatment of the anaemia of rheumatoid arthritis with recombinant human erythropoietin; clinical and in vitro studies. Arthritis Rheum 1989; 32:638–42.

24.

Abels

. Use of recombinant human erythropoietin in the treatment of anaemia in patients who have cancer. Semin Oncol 1992; 19(Suppl 8):29–35.

25.

Goodnough

Rudnick

Price

. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989; 321:1163–8.

26.

Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993; 341:1227–32.

27.

Temple

Langan

Deary

Winney

. Recombinant human erythropoietin improves cognitive function in chronic haemodialysis patients. Nephrol Dial Transplant 1992; 7:240–5.

28.

European erythropoietin symposium. Moving into the second decade of clinical experience in CRF. Nephrol Dial Transplant 1995; 10(Suppl 2):1–109.

29.

Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 1990; 300:573–8.

30.

Besarab

Bolton

Browne

. The effects of normal as compared with low haematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584–90.

31.

Salonen

Nyyssonen

Korpela

. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86:803–11.

32.

Collins

Ebbern

. Frequent iv iron dosing is associated with higher infectious deaths. J Am Soc Nephrol 1997; 8:190A.

33.

Foley

Parfrey

Sarnak

. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9:S16–S23.

34.

Silberberg

Barre

Prichard

Sniderman

. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36:286–90.

35.

Pascual

Teruel

Moya

. Regression of left ventricular hypertrophy after partial correction of anaemia with erythropoietin in patients on dialysis. Clin Nephrol 1991; 35:280–7.

36.

Tagawa

Nagano

Saito

. Echocardiographic findings in haemodialysis patients treated with recombinant human erythropoietin. Proposal for the haematocrit most beneficial to haemodynamics. Clin Nephrol 1991; 35:35–8.

37.

Meyer

Levey

. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on Cardiovascular Disease. J Am Soc Nephrol 1998; 9b:S31–S42.